Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$19.79
0.914.82%
At close: -
$19.78
-0.01-0.06%
After Hours: 7:59 PM EDT
Comments
Loading...
SI-BONE Analyst Ratings and Price Targets | NASDAQ:SIBN | Benzinga
SI-BONE Inc has a consensus price target of $24.82 based on the ratings of 11 analysts. The high is $32 issued by Citizens Capital Markets on February 25, 2025. The low is $19 issued by Morgan Stanley on August 6, 2024. The 3 most-recent analyst ratings were released by Truist Securities, Cantor Fitzgerald, and Needham on May 6, 2025, respectively. With an average price target of $23.67 between Truist Securities, Cantor Fitzgerald, and Needham, there's an implied 19.67% upside for SI-BONE Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
Cantor Fitzgerald
Needham
Citizens Capital Markets
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for SI-BONE
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/06/2025 | Buy Now | 11.24% | Truist Securities | Samuel Brodovsky65% | $20 → $22 | Maintains | Buy | Get Alert |
| 05/06/2025 | Buy Now | 26.41% | Cantor Fitzgerald | Ross Osborn45% | $25 → $25 | Reiterates | Overweight → Overweight | Get Alert |
| 05/06/2025 | Buy Now | 21.35% | Needham | David Saxon56% | $24 → $24 | Reiterates | Buy → Buy | Get Alert |
| 02/25/2025 | Buy Now | 61.8% | Citizens Capital Markets | David Turkaly51% | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/25/2025 | Buy Now | 11.24% | Truist Securities | Samuel Brodovsky65% | $18 → $22 | Reiterates | Buy → Buy | Get Alert |
| 02/25/2025 | Buy Now | 26.41% | Cantor Fitzgerald | Ross Osborn45% | $25 → $25 | Reiterates | Overweight → Overweight | Get Alert |
| 02/25/2025 | Buy Now | 21.35% | Needham | David Saxon56% | $20 → $24 | Maintains | Buy | Get Alert |
| 01/13/2025 | Buy Now | -3.93% | Needham | David Saxon56% | $19 → $19 | Reiterates | Buy → Buy | Get Alert |
| 11/20/2024 | Buy Now | -3.93% | Needham | David Saxon56% | $19 → $19 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | -8.99% | Truist Securities | Samuel Brodovsky65% | $16 → $18 | Maintains | Buy | Get Alert |
| 11/13/2024 | Buy Now | -3.93% | Needham | David Saxon56% | $19 → $19 | Reiterates | Buy → Buy | Get Alert |
| 10/14/2024 | Buy Now | -19.1% | Truist Securities | Samuel Brodovsky65% | $18 → $16 | Maintains | Buy | Get Alert |
| 08/06/2024 | Buy Now | -3.93% | Morgan Stanley | Drew Ranieri47% | $21 → $19 | Maintains | Overweight | Get Alert |
| 08/06/2024 | Buy Now | -8.99% | Truist Securities | Samuel Brodovsky65% | $20 → $18 | Maintains | Buy | Get Alert |
| 08/06/2024 | Buy Now | -3.93% | Needham | David Saxon56% | $27 → $19 | Maintains | Buy | Get Alert |
| 07/15/2024 | Buy Now | 6.18% | Morgan Stanley | Drew Ranieri47% | $25 → $21 | Maintains | Overweight | Get Alert |
| 05/07/2024 | Buy Now | 61.8% | JMP Securities | David Turkaly51% | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/07/2024 | Buy Now | 36.52% | Needham | David Saxon56% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | Buy Now | 26.41% | Morgan Stanley | Drew Ranieri47% | $26 → $25 | Maintains | Overweight | Get Alert |
| 04/03/2024 | Buy Now | 36.52% | Needham | David Saxon56% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
| 03/28/2024 | Buy Now | 26.41% | Piper Sandler | Matt O'Brien52% | → $25 | Initiates | → Overweight | Get Alert |
| 02/27/2024 | Buy Now | 31.46% | Morgan Stanley | Drew Ranieri47% | $25 → $26 | Maintains | Overweight | Get Alert |
| 02/27/2024 | Buy Now | 26.41% | Cantor Fitzgerald | Ross Osborn45% | $25 → $25 | Maintains | Overweight | Get Alert |
| 02/27/2024 | Buy Now | 21.35% | Truist Securities | Samuel Brodovsky65% | $26 → $24 | Reiterates | Buy → Buy | Get Alert |
| 12/22/2023 | Buy Now | 31.46% | Truist Securities | David Rescott62% | $25 → $26 | Maintains | Buy | Get Alert |
| 12/04/2023 | Buy Now | 26.41% | Needham | David Saxon56% | → $25 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2023 | Buy Now | 26.41% | Cantor Fitzgerald | Ross Osborn45% | $30 → $25 | Maintains | Overweight | Get Alert |
| 11/07/2023 | Buy Now | 26.41% | Morgan Stanley | Drew Ranieri47% | $30 → $25 | Maintains | Overweight | Get Alert |
| 11/07/2023 | Buy Now | 26.41% | Needham | David Saxon56% | $32 → $25 | Maintains | Buy | Get Alert |
| 09/26/2023 | Buy Now | 51.69% | Cantor Fitzgerald | Ross Osborn45% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | Buy Now | 51.69% | Cantor Fitzgerald | Ross Osborn45% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 08/09/2023 | Buy Now | 51.69% | Cantor Fitzgerald | Ross Osborn45% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 08/08/2023 | Buy Now | 56.75% | Truist Securities | David Rescott62% | $33 → $31 | Maintains | Buy | Get Alert |
| 08/08/2023 | Buy Now | 61.8% | Needham | David Saxon56% | → $32 | Reiterates | Buy → Buy | Get Alert |
| 07/19/2023 | Buy Now | 66.86% | Truist Securities | David Rescott62% | $28 → $33 | Maintains | Buy | Get Alert |
| 07/12/2023 | Buy Now | 61.8% | Needham | David Saxon56% | $27 → $32 | Maintains | Buy | Get Alert |
| 05/31/2023 | Buy Now | 51.69% | Morgan Stanley | Drew Ranieri47% | $27 → $30 | Maintains | Overweight | Get Alert |
| 05/02/2023 | Buy Now | 51.69% | Cantor Fitzgerald | Ross Osborn45% | $24 → $30 | Maintains | Overweight | Get Alert |
| 05/02/2023 | Buy Now | 36.52% | Morgan Stanley | Drew Ranieri47% | $22 → $27 | Maintains | Overweight | Get Alert |
| 05/02/2023 | Buy Now | 61.8% | JMP Securities | David Turkaly51% | → $32 | Reiterates | → Market Outperform | Get Alert |
| 05/02/2023 | Buy Now | 36.52% | Canaccord Genuity | Kyle Rose68% | $24 → $27 | Maintains | Buy | Get Alert |
| 05/02/2023 | Buy Now | 36.52% | Needham | David Saxon56% | $24 → $27 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | 31.46% | Truist Securities | David Rescott62% | $21 → $26 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | 21.35% | Cantor Fitzgerald | Ross Osborn45% | $22 → $24 | Maintains | Overweight | Get Alert |
| 02/28/2023 | Buy Now | 21.35% | Canaccord Genuity | Kyle Rose68% | $21 → $24 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | 11.24% | Morgan Stanley | Drew Ranieri47% | $18 → $22 | Maintains | Overweight | Get Alert |
| 02/28/2023 | Buy Now | 21.35% | Needham | David Saxon56% | $20 → $24 | Maintains | Buy | Get Alert |
| 01/31/2023 | Buy Now | 6.18% | Truist Securities | Richard Newitter74% | $17 → $21 | Maintains | Buy | Get Alert |
| 01/06/2023 | Buy Now | -8.99% | Morgan Stanley | Drew Ranieri47% | $21 → $18 | Maintains | Overweight | Get Alert |
| 12/20/2022 | Buy Now | -14.04% | Truist Securities | David Rescott62% | $20 → $17 | Maintains | Buy | Get Alert |
| 11/08/2022 | Buy Now | 6.18% | Morgan Stanley | Drew Ranieri47% | $22 → $21 | Maintains | Overweight | Get Alert |
| 11/08/2022 | Buy Now | 61.8% | JMP Securities | David Turkaly51% | $36 → $32 | Maintains | Market Outperform | Get Alert |
| 11/08/2022 | Buy Now | 11.24% | Needham | David Saxon56% | $24 → $22 | Maintains | Buy | Get Alert |
| 10/12/2022 | Buy Now | 1.13% | Jefferies | Matthew Taylor69% | → $20 | Initiates | → Buy | Get Alert |
| 10/11/2022 | Buy Now | 11.24% | Morgan Stanley | Drew Ranieri47% | $21 → $22 | Maintains | Overweight | Get Alert |
| 08/09/2022 | Buy Now | 6.18% | Morgan Stanley | Drew Ranieri47% | $18 → $21 | Maintains | Overweight | Get Alert |
| 08/09/2022 | Buy Now | 21.35% | Needham | David Saxon56% | $28 → $24 | Maintains | Buy | Get Alert |
| 07/15/2022 | Buy Now | -8.99% | Morgan Stanley | Drew Ranieri47% | $22 → $18 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for SI-BONE (SIBN) stock?
The latest price target for SI-BONE (NASDAQ:SIBN) was reported by Truist Securities on May 6, 2025. The analyst firm set a price target for $22.00 expecting SIBN to rise to within 12 months (a possible 11.24% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for SI-BONE (SIBN)?
The latest analyst rating for SI-BONE (NASDAQ:SIBN) was provided by Truist Securities, and SI-BONE maintained their buy rating.
When was the last upgrade for SI-BONE (SIBN)?
There is no last upgrade for SI-BONE
When was the last downgrade for SI-BONE (SIBN)?
There is no last downgrade for SI-BONE.
When is the next analyst rating going to be posted or updated for SI-BONE (SIBN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SI-BONE, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SI-BONE was filed on May 6, 2025 so you should expect the next rating to be made available sometime around May 6, 2026.
Is the Analyst Rating SI-BONE (SIBN) correct?
While ratings are subjective and will change, the latest SI-BONE (SIBN) rating was a maintained with a price target of $20.00 to $22.00. The current price SI-BONE (SIBN) is trading at is $19.78, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
